Raymond James Financial Services Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-536
Closed -$2.5K 3388
2023
Q2
$2.5K Buy
+536
New +$2.63K ﹤0.01% 3232
2022
Q4
Sell
-213
Closed -$4K 3445
2022
Q3
$4K Hold
213
﹤0.01% 3239
2022
Q2
$11K Hold
213
﹤0.01% 3202
2022
Q1
$30K Sell
213
-4
-2% -$584 ﹤0.01% 3233
2021
Q4
$37K Buy
217
+25
+13% +$9.32K ﹤0.01% 3214
2021
Q3
$96K Sell
192
-4
-2% -$1.85K ﹤0.01% 3124
2021
Q2
$98K Buy
196
+2
+1% +$1.07K ﹤0.01% 3141
2021
Q1
$98K Buy
194
+2
+1% +$1.03K ﹤0.01% 3043
2020
Q4
$92K Sell
192
-27
-12% -$8.86K ﹤0.01% 2864
2020
Q3
$63K Buy
219
+5
+2% +$1.24K ﹤0.01% 2748
2020
Q2
$41K Buy
214
+17
+9% +$2.83K ﹤0.01% 2725
2020
Q1
$25K Buy
197
+16
+9% +$2.9K ﹤0.01% 2358
2019
Q4
$32K Hold
181
﹤0.01% 2784
2019
Q3
$27K Buy
181
+17
+10% +$2.27K ﹤0.01% 2734
2019
Q2
$19K Sell
164
-1
-0.6% -$158 ﹤0.01% 2796
2019
Q1
$28K Hold
165
﹤0.01% 2737
2018
Q4
$20K Sell
165
-51
-24% -$7.83K ﹤0.01% 2513
2018
Q3
$33K Buy
216
+33
+18% +$13.8K ﹤0.01% 2743
2018
Q2
$121K Sell
183
-30
-14% -$22.4K ﹤0.01% 2585
2018
Q1
$217K Buy
213
+133
+166% +$111K ﹤0.01% 2208
2017
Q4
$98K Buy
+80
New +$37.6K ﹤0.01% 2379

Other funds holding AMPE

Raymond James Financial Services Advisors's AMPE Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 536 shares — an estimated $2.5K sold.

Raymond James Financial Services Advisors first reported a position in AMPE in Q4 2017 and held it in 21 quarters. The position peaked at $217K in Q1 2018. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Raymond James Financial Services Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 536 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $2.5K.
  • Raymond James Financial Services Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 21 quarters.
  • Raymond James Financial Services Advisors's Ampio Pharmaceuticals Inc. position peaked at $217K in Q1 2018.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.